nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

The phase 4 ABOUND.70+ trial assessed the safety and efficacy of nab-paclitaxel/carboplatin continuously or with a 1-week break between cycles in elderly patients with advanced non-small cell lung cancer (NSCLC). Patients ≥70 years with locally advanced/metastatic NSCLC were randomized 1:1 to first-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Langer, Corey J., Kim, Edward S., Anderson, Eric C., Jotte, Robert M., Modiano, Manuel, Haggstrom, Daniel E., Socoteanu, Matei P., Smith, David A., Dakhil, Christopher, Konduri, Kartik, Berry, Tymara, Ong, Teng J., Sanford, Alexandra, Amiri, Katayoun, Goldman, Jonathan W., Weiss, Jared
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066531/
https://ncbi.nlm.nih.gov/pubmed/30087851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00262
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados